⌘K

Login Start Free

Home/Filings/4/0001235802-23-000029

4//SEC Filing

Lewis Tanya 4

Accession 0001235802-23-000029

CIK 0001401040other

View on SEC.gov Company Profile

Filed

Mar 5, 7:00 PM ET

Accepted

Mar 6, 5:14 PM ET

Size

5.9 KB

Accession

0001235802-23-000029

Insider Transaction Report

Form 4

Period: 2023-03-01

DiaMedica Therapeutics Inc.DMAC

Director

Transactions

Award
Stock option (right to buy)
2023-03-01+26,443→ 26,443 total
Exercise: $1.77Exp: 2033-02-28→ Common Shares (26,443 underlying)

Holdings

Voting Common Shares, no par value per share
0

Footnotes (1)

[F1]Vests in 12 nearly equal quarterly installments over three years.

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

DiaMedica Therapeutics Inc.

CIK 0001401040

Entity typeother

Related Parties

1

filerCIK 0001451038

Filing Metadata

Form type: 4
Filed: Mar 5, 7:00 PM ET
Accepted: Mar 6, 5:14 PM ET
Size: 5.9 KB

View on SEC.gov